NCT06094205Recruiting
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)
Understanding and Restoring Speech Production Using an Intracortical Brain-computer Interface
Source: ClinicalTrials.gov · Last updated 1 Dec 2025
Brief summary (registry, in English)
The goal of this study is to improve our understanding of speech production, and to translate this into medical devices called intracortical brain-computer interfaces (iBCIs) that will enable people who have lost the ability to speak fluently to communicate via a computer just by trying to speak.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 2 (estimated)
- First submitted
- 18 Sept 2023
- Start date
- 16 Oct 2023
- Primary completion date
- 31 Aug 2027
- Lead sponsor
- Leigh R. Hochberg, MD, PhD.
- Diseases
- ALS (motor neurone disease)
- NCT number
- NCT06094205
What you commit to
- Study type: Interventional
- Planned participants: 2
- From 16 Oct 2023 to the primary completion date, 31 Aug 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Chronic oral or intravenous steroids or immunosuppressive therapy
Other illness
- Visual impairment such that extended viewing of a computer monitor would be difficult even with ordinary corrective lenses
- Other serious disease or disorder that could seriously affect ability to participate in the study
- (There are additional exclusion criteria)
Who the study is looking for
- Between 18 and 80 years of age
- Clinical diagnosis of spinal cord injury, brainstem stroke, muscular dystrophy, amyotrophic lateral sclerosis or other motor neuron disorders
- Complete or incomplete tetraplegia (quadriplegia)
- Must live within a three-hour drive of the Study site and geographically stable for at least 15 months after enrollment.
- (There are additional inclusion criteria)
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of California - Davis Coordinator of this site? Confirm its status | Sacramento | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.